سعر هايبرس دى 20 كبسولة 2022

Fixed-dose antihypertensive capsules (Rameda, Egypt) combining the cardioselective beta-blocker atenolol with the thiazide diuretic hydrochlorothiazide and the potassium-sparing diuretic amiloride; 20 capsules. Strengths per capsule were not confirmed by the Egyptian sources.

• Atenolol: contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock and overt cardiac failure.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Amiloride/hydrochlorothiazide: do not use with hyperkalaemia (serum potassium > 5.5 mEq/L), with other potassium-conserving agents (e.g. spironolactone, triamterene) or potassium supplements, or in anuria, acute or chronic renal insufficiency or diabetic nephropathy.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Hyperkalaemia, potentially fatal, may occur with amiloride-containing combinations (about 1-2% without renal impairment or diabetes; higher with them); monitor serum potassium closely, especially at initiation, dose changes and intercurrent illness affecting renal function.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Do not stop atenolol abruptly in patients with coronary artery disease: severe exacerbation of angina, myocardial infarction and ventricular arrhythmias have been reported after abrupt withdrawal of beta-blockers.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Potassium supplements, potassium-containing salt substitutes, other potassium-sparing diureticsConcomitant use with amiloride can cause rapid rises in serum potassium; avoid except in severe refractory hypokalaemia with close monitoring.DailyMed (U.S. National Library of Medicine)

• Monitor serum potassium (and renal function) regularly during therapy with amiloride-containing products.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

English text not available for this section.